(Q72462272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Beta-adrenergic blocking agents for the treatment of angina pectoris (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

26 October 2019

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

1 July 2023

author name string

W. C. Elliott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5807587

1 July 2023

J. M. Stone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5807587

1 July 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5807587

1 July 2023

publication date

1 July 1969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

26 October 2019

number of pages

16

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0033062069900371?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

https://api.elsevier.com/content/article/PII:0033062069900371?httpAccept=text/plain

1 July 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Progress in Cardiovascular Diseases

1 July 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

83-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

Effects of propranolol on exercise tolerance in angina pectoris

26 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Multicenter trial of propranolol in angina pectoris

1 July 2023

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol and angina pectoris.

1 July 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships

1 July 2023

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of iproveratril and nitroglycerin in the heart and coronary circulation of dogs

1 July 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Evaluation of the cardiac effects of several beta adrenergic blocking agents

1 July 2023

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE

1 July 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Adrenergic Receptor Activity in the Coronary Arteries of the Unanesthetized Dog

1 July 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Hemodynamic changes after beta adrenergic blockade

1 July 2023

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of Propranolol on Systemic and Coronary Hemodynamics at Rest and during Simulated Exercise

1 July 2023

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of beta adrenergic blockade on heart size.

1 July 2023

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The pharmacology of beta sympathetic blockade

1 July 2023

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Modification of cardiovascular responses by propranolol

1 July 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

THE HAeMODYNAMIC EFFECTS OF -SYMPATHETIC BLOCKADE

1 July 2023

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Systemic circulatory response to stress of simulated flight and to physical exercise before and after propranolol blockade

1 July 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Hemodynamic responses to beta-adrenergic blockade in dogs.

1 July 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions

1 July 2023

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man

1 July 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Cardiac output after beta-adrenergic blockade in ischaemic heart disease

1 July 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

A Comparative Study of Nitroglycerin and Propranolol

1 July 2023

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Beta-adrenergic blocking effects of propranolol

1 July 2023

32

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of propranolol (inderal) on exercise tolerance in angina pectoris

1 July 2023

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Physiological differences between the effects of neuronally released and bloodborne norepinephrine on beta adrenergic receptors in the arterial bed of the dog

1 July 2023

34

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Control of the splanchnic circulation in man. Role of beta-adrenergic receptors.

1 July 2023

35

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism of the human heart

1 July 2023

36

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism

1 July 2023

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Oxidation reduction in heart muscle. Theoretical and clinical considerations

1 July 2023

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Determinants of coronary flow and myocardial oxygen consumption

1 July 2023

39

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Interrelation between cardiac oxygen consumption and coronary blood flow

1 July 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Myocardial oxygen consumption and coronary blood flow during potassium-induced cardiac arrest and during ventricular fibrillation

1 July 2023

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Cardiac oxygen metabolism and control of the coronary circulation

1 July 2023

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Regulation of Coronary Flow

1 July 2023

43

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

CONTROL OF CORONARY BLOOD FLOW BY AN AUTOREGULATORY MECHANISM

1 July 2023

45

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow

1 July 2023

46

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Hypoxemia and coronary blood flow

1 July 2023

48

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Velocity of contraction as a determinant of myocardial oxygen consumption

1 July 2023

49

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Left ventricular pressure-volume relationships and myocardial oxygen consumption in the isolated heart

1 July 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

REGULATION OF CORONARY BLOOD FLOW

1 July 2023

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The relation of cardiac effort to myocardial oxygen consumption and coronary flow

1 July 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow

1 July 2023

53

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The high permeability of human red cells to adenine and hypoxanthine and their ribosides

1 July 2023

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of epinephrine and norepinephrine on coronary circulation

1 July 2023

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The physiological role of fibres. I. The effect of the coronary vasomotors on the systemic blood pressure

1 July 2023

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The physiological role of coronary constrictor fibres. II. The role of coronary vasomotors in metabolic adaptation of the coronaries

1 July 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Separation of cardioaccelerator and coronary vasomotor fibers in the dog

1 July 2023

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

1 July 2023

The coronary circulation

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

INFLUENCE OF NOREPINEPHRINE ON MYOCARDIAL OXYGEN CONSUMPTION UNDER CONTROLLED HEMODYNAMIC CONDITIONS

1 July 2023

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease

1 July 2023

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of Propranolol and Its Stereoisomers upon Coronary Vascular Resistance

1 July 2023

64

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

AN INTRINSIC ADRENERGIC VASODILATOR MECHANISM IN THE CORONARY VASCULAR BED OF THE DOG

1 July 2023

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Sympathetic control of coronary circulation.

1 July 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Myocardial vascular reactivity after beta-adrenergic blockade

1 July 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

EFFECTS OF NOREPINEPHRINE ON THE CORONARY CIRCULATION IN MAN

1 July 2023

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Beta-receptors in coronary vessels

1 July 2023

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of Left Ventricular Hypertension, Ischemia and Vasoactive Drugs on the Myocardial Distribution of Coronary Flow

1 July 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Phasic myocardial blood flow in hemorrhagic hypotension. Effect of beta sympathetic blockade

1 July 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Drug inhibition of catecholamine-induced metabolic effects in humans

1 July 2023

74

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications

1 July 2023

75

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Myocardial uptake of free fatty acids and carbohydrates after beta adrenergic blockade

1 July 2023

76

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications

1 July 2023

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

A neural action of pronethalol.

1 July 2023

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Clinical efficacy of propranolol as a local anaesthetic

1 July 2023

79

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

HEMODYNAMIC STUDIES AND CLINICAL EXPERIENCE WITH NETHALIDE, A BETA-ADRENERGIC BLOCKING AGENT

1 July 2023

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

1 July 2023

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol in hypertension

1 July 2023

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of propranolol on the peripheral circulation

1 July 2023

84

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol in hypertension

1 July 2023

85

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Myocardial metabolism in cardiac hypoxia

1 July 2023

86

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of interrupted coronary flow upon myocardial metabolism and contractility

1 July 2023

87

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Coronary insufficiency in man. Physiologic and electrocardiographic correlation

1 July 2023

88

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Patterns of human myocardial oxygen extraction during rest and exercise

1 July 2023

89

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Anaerobic myocardial metabolism

1 July 2023

90

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Coronary heart disease. Clinical, cinearteriographic and metabolic correlations

1 July 2023

91

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Mechanisms of angina in aortic stenosis

1 July 2023

92

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

1 July 2023

93

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris

1 July 2023

94

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Measurement of the Angina Threshold Using Atrial Pacing: A New Technique for the Study of Angina Pectoris

1 July 2023

95

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris

1 July 2023

96

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade

1 July 2023

97

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The anginal syndrome with normal coronary arteriography

1 July 2023

98

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide)

1 July 2023

103

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS.

1 July 2023

104

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol in the therapy of angina pectoris

1 July 2023

105

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA OF EFFORT.

1 July 2023

106

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

USE OF PROPRANOLOL IN ANGINA PECTORIS

1 July 2023

107

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

EFFECT OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS: PRELIMINARY REPORT.

1 July 2023

110

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The prophylactic value of propranolol in angina pectoris

1 July 2023

113

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol in patients with angina pectoris.

1 July 2023

114

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

NONSPECIFIC AND BETA-ADRENERGIC BLOCKING EFFECTS OF ALDERLIN IN ANGINA PECTORIS

1 July 2023

115

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Unwanted effects of propranolol.

1 July 2023

117

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

EFFECT OF CORONARY VASODILATOR DRUGS ON RETROGRADE FLOW IN AREAS OF CHRONIC MYOCARDIAL ISCHEMIA

1 July 2023

119

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects

1 July 2023

120

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work.

1 July 2023

121

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Myocardial blood flow in man measured by a coincidence counting system and a single bolus of 84rubidium chloride. Effect of nitroglycerin

1 July 2023

122

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol and isosorbide dinitrate synergism in angina pectoris

1 July 2023

123

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

THE EFFECT OF A BETA-ANDRENERGIC-BLOCKING AGENT (NETHALIDE) AND NITROGLYCERIN ON EXERCISE TOLERANCE IN ANGINA PECTORIS

1 July 2023

124

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease

1 July 2023

125

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

1 July 2023

126

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effect of propranolol on ventilatory function

1 July 2023

127

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Bronchial response to beta-adrenergic blockade

1 July 2023

128

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia

1 July 2023

129

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Propranolol and hypoglycemia

1 July 2023

130

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Hypoglycaemia precipitated by propranolol

1 July 2023

131

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Beta-adrenergic blockade in cardiac infarction

1 July 2023

132

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Cardiovascular effects of glucagon in man

1 July 2023

134

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Early changes in collateral flow following coronary artery ligation: the role of the sympathetic nervous system

1 July 2023

136

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Observations on the mechanisms of infarction in the dog after experimental occlusion of the coronary artery

1 July 2023

137

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

Histochemical and electron microscopic study of heart muscle after beta-adrenergic blockade

1 July 2023

138

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90037-1

1 July 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5807587%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference